148 related articles for article (PubMed ID: 27764019)
1. FUNCTIONAL AND ANATOMICAL OUTCOMES OF CHOROIDAL NEOVASCULARIZATION COMPLICATING BEST1-RELATED RETINOPATHY.
Khan KN; Mahroo OA; Islam F; Webster AR; Moore AT; Michaelides M
Retina; 2017 Jul; 37(7):1360-1370. PubMed ID: 27764019
[TBL] [Abstract][Full Text] [Related]
2. Ranibizumab for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophy: one-year results.
Mimoun G; Caillaux V; Querques G; Rothschild PR; Puche N; Souied EH
Retina; 2013 Mar; 33(3):513-21. PubMed ID: 23400081
[TBL] [Abstract][Full Text] [Related]
3. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FOR THE DETECTION OF SECONDARY CHOROIDAL NEOVASCULARIZATION IN VITELLIFORM MACULAR DYSTROPHY.
Stattin M; Ahmed D; Glittenberg C; Krebs I; Ansari-Shahrezaei S
Retin Cases Brief Rep; 2020; 14(1):49-52. PubMed ID: 28817420
[TBL] [Abstract][Full Text] [Related]
4. Autosomal recessive best vitelliform macular dystrophy: report of a family and management of early-onset neovascular complications.
Iannaccone A; Kerr NC; Kinnick TR; Calzada JI; Stone EM
Arch Ophthalmol; 2011 Feb; 129(2):211-7. PubMed ID: 21320969
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab for inflammatory choroidal neovascularization: results from the Pan-American Collaborative Retina Study Group at 24 months.
Arevalo JF; Adan A; Berrocal MH; Espinoza JV; Maia M; Wu L; Roca JA; Quiroz-Mercado H; Ruiz-Moreno JM; Serrano MA;
Retina; 2011 Feb; 31(2):353-63. PubMed ID: 20890239
[TBL] [Abstract][Full Text] [Related]
6. SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FEATURES IN DIFFERENT STAGES OF BEST VITELLIFORM MACULAR DYSTROPHY.
Battaglia Parodi M; Iacono P; Romano F; Bandello F
Retina; 2018 May; 38(5):1041-1046. PubMed ID: 28376040
[TBL] [Abstract][Full Text] [Related]
7. One-year outcomes of less frequent bevacizumab in age-related macular degeneration.
Sonmez K; Sonmez PA; Ozkan SS; Atmaca LS
Retina; 2011 Apr; 31(4):645-53. PubMed ID: 21358363
[TBL] [Abstract][Full Text] [Related]
8. Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Month Results.
Koizumi H; Kano M; Yamamoto A; Saito M; Maruko I; Sekiryu T; Okada AA; Iida T
Ophthalmology; 2016 Mar; 123(3):617-24. PubMed ID: 26686967
[TBL] [Abstract][Full Text] [Related]
9. Choroidal neovascular membrane in paediatric patients: clinical characteristics and outcomes.
Padhi TR; Anderson BJ; Abbey AM; Yonekawa Y; Stem M; Alam D; Modi RR; Savla LP; Trese MT; Capone A; Drenser KA; Besirli CG
Br J Ophthalmol; 2018 Sep; 102(9):1232-1237. PubMed ID: 29217515
[TBL] [Abstract][Full Text] [Related]
10. Optical coherence tomography angiography in adult-onset foveomacular vitelliform dystrophy.
Querques G; Zambrowski O; Corvi F; Miere A; Semoun O; Srour M; Souied EH
Br J Ophthalmol; 2016 Dec; 100(12):1724-1730. PubMed ID: 26951771
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics, Choroidal Neovascularization, and Predictors of Visual Outcomes in Acquired Vitelliform Lesions.
Balaratnasingam C; Hoang QV; Inoue M; Curcio CA; Dolz-Marco R; Yannuzzi NA; Dhrami-Gavazi E; Yannuzzi LA; Freund KB
Am J Ophthalmol; 2016 Dec; 172():28-38. PubMed ID: 27640006
[TBL] [Abstract][Full Text] [Related]
12. [Choroidal neovascularization complicating Best's vitelliform macular dystrophy in a child].
Elkhoyaali A; Chatoui S; Bercheq N; Elouatassi N; Zerrouk R; Elasri F; Reda K; Oubaaz A
J Fr Ophtalmol; 2016 Jan; 39(1):69-73. PubMed ID: 26707756
[TBL] [Abstract][Full Text] [Related]
13. Focal Choroidal Excavation in Retinal Dystrophies.
Braimah IZ; Rapole S; Dumpala S; Chhablani J
Semin Ophthalmol; 2018; 33(2):161-166. PubMed ID: 27533784
[TBL] [Abstract][Full Text] [Related]
14. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA;
Retina; 2008; 28(10):1387-94. PubMed ID: 18827735
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab for choroidal neovascularization secondary to Best vitelliform macular dystrophy in a 6-year-old child.
Chhablani J; Jalali S
Eur J Ophthalmol; 2012; 22(4):677-9. PubMed ID: 22139615
[TBL] [Abstract][Full Text] [Related]
16. Clinical and angiographic characterization of choroidal neovascularization in diabetic retinopathy.
Singh SR; Parameswarappa DC; Govindahari V; Lupidi M; Chhablani J
Eur J Ophthalmol; 2021 Mar; 31(2):584-591. PubMed ID: 31984769
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
Avery RL; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ
Ophthalmology; 2006 Mar; 113(3):363-372.e5. PubMed ID: 16458968
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.
Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N
Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461
[TBL] [Abstract][Full Text] [Related]
19. Best Vitelliform Macular Dystrophy Natural History Study Report 1: Clinical Features and Genetic Findings.
Laich Y; Georgiou M; Fujinami K; Daich Varela M; Fujinami-Yokokawa Y; Hashem SA; Cabral de Guimaraes TA; Mahroo OA; Webster AR; Michaelides M
Ophthalmology; 2024 Jul; 131(7):845-854. PubMed ID: 38278445
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Results of Photodynamic Therapy for Choroidal Neovascularization in Pediatric Patients with Best Vitelliform Macular Dystrophy.
Sodi A; Murro V; Caporossi O; Passerini I; Bacci GM; Caputo R; Menchini U
Ophthalmic Genet; 2015 Jun; 36(2):168-74. PubMed ID: 25675349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
